Humanigen (HGEN) Environmental, Social & Governance (ESG) Data

Employees

Data from SEC filings

Employee count

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Agriculture Air Environment Environmental Escape Hazard Materials Nature Nuclear Offset Package Packaging Pandemic Raw Materials Recycling Regenerative Renewable Toxic Waste Wind Access African American Asian Benefits Black California Consumer Privacy Act Collective Bargaining Community Customer Cybersecurity Data Privacy Data Security Death Demographics Diversity Employee Engagement Ethnic Ethnicity Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hispanic Human Capital Human Resources Injury Minority Privacy Product Safety Recall Recruitment Reimbursement Retention Retirement Safety Satisfaction Skills Social Societal Society Stakeholder Supplier Supply Chain Talent Training Union Volunteer Workers Action Plan Assessment Assurance Attorneys General Audit Bonus Bribery Chronic Class Action Lawsuit Classified Commitment Corporate Governance Corporate Purpose Department of Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Independence Independent Innovation Innovative Investigation Lawsuit Leadership Litigant Litigation Long-term Majority Oversee Oversight Plaintiff Pledging Purpose Quality Standard R&D Recoup Reputation Reputational Research and Development Responsibility Responsible Strategy Sustainable Targets Tax Transparency

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

The 2021 Annual Meeting of Stockholders (the “Annual Meeting”) of Humanigen, Inc. (the “Company”) was held on June 17, 2021. Proxies for the Annual Meeting were solicited by the Board of Directors of the Company (the “Board”) pursuant to Section 14(a) of the Securities Exchange Act of 1934, as amended, and there was no solicitation in opposition. There were 58,656,689 shares of common stock entitled to vote at the Annual Meeting. A total of 39,983,163 shares were represented at the Annual Meeting in person or by proxy. The final votes on the proposals presented at the Annual Meeting were as follows:

Proposal No. 1

Cameron Durrant, M.D, MBA, Ronald Barliant, JD, Ranier Boehm, M.D., MBA, Cheryl Buxton, M.A., and Dale Chappell, M.D., MBA, were elected by a plurality of the votes entitled to vote on the election of directors, to hold office until the 2022 Annual Meeting of Stockholders by the following vote (in each case until their successors are elected and qualified, or until their earlier death, resignation or removal):

Nominee

Cameron Durrant, M.D, MBA	26,255,469	2,923,125	10,804,569
Ronald Barliant, JD	26,058,454	3,120,140	10,804,569
Ranier Boehm, M.D., MBA	26,247,254	2,931,340	10,804,569
Cheryl Buxton, M.A.	25,056,609	4,121,985	10,804,569
Dale Chappell, M.D., MBA	28,228,502	950,092	10,804,569

Proposal No. 2

The selection by the Audit Committee of the Board of HORNE LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021 was ratified by the following vote:

For					Against					Abstain
	39,635,344					181,870					165,949

Proposal No. 3

The compensation paid to the Company’s named executive officers, as disclosed pursuant to